FOXM1 overexpression could be a feature of CCA tumorigenesis, and therefore, FOXM1 and its gene transcription signature can be exploited as a useful biomarker for early CCA diagnosis. The gene discussed is FOXM1; the disease is cholangiocarcinoma.